List of works - Peter Gibbs

A critical review of the Glasgow Prognostic Score for colorectal cancer

scientific article published on 01 June 2008

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer

scientific article

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

scientific article published on 07 December 2013

APER rate has multiple limitations as an indicator of quality in rectal cancer surgery

scientific article published on 01 December 2008

Adjuvant chemotherapy use among older patients with stage III colon cancer

scientific article published on 01 June 2010

An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer.

scientific article published on 24 June 2012

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion

scientific article published on 3 January 2013

Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria

scientific article published on 13 August 2015

Assessing aneuploidy with repetitive element sequencing

scientific article published on 19 February 2020

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

scientific article published on 08 November 2012

Author reply: To PMID 22372920.

scientific article published in July 2013

BioGrid Australia facilitates collaborative medical and bioinformatics research across hospitals and medical research institutes by linking data from diverse disease and data types

scientific article

Blood-based protein biomarker panel for the detection of colorectal cancer

scientific article

Cancer classification using the Immunoscore: a worldwide task force

scientific article

Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer

scientific article published on 09 November 2009

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

scientific article published on May 2008

Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?

scientific article

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

scientific article published on 17 October 2019

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

scientific article

Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.

scientific article

Colorectal cancer screening: ensuring benefits outweigh the risks

scientific article published on 01 August 2008

Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology.

scientific article

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

scientific article published on 5 July 2010

Comparing oncological outcomes of laparoscopic versus open surgery for colon cancer: Analysis of a large prospective clinical database.

scientific article published on 24 February 2015

Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

scientific article published in August 2007

Comparison of ECOG/WHO Performance Status and ASA Score as a Measure of Functional Status

scientific article published on 01 July 2014

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

scientific article

Cytosine methylation profiling of cancer cell lines.

scholarly article

DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers

scientific article published on December 2008

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

scientific article published on 18 January 2018

Detection of circulating tumor DNA in early- and late-stage human malignancies

scientific article (publication date: 19 February 2014)

Developing a national database for metastatic colorectal cancer management: perspectives and challenges.

scientific article published in November 2013

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.

scientific article published on 22 October 2012

Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives?

scientific article published on 26 December 2012

Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.

scientific article published on September 2010

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

article by John J. McNeil et al published 18 October 2018 in The New England Journal of Medicine

Effect of Aspirin on Disability-free Survival in the Healthy Elderly

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.

scientific article published in July 2008

Financial incentives in cancer care and impact on prescribing practice.

scientific article published on 15 July 2013

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer

scientific article

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study

scientific article

Guesstimates are not good enough for determining what is happening in routine care.

scientific article published on 9 November 2010

Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review

scientific article published on 22 April 2020

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.

scientific article published on 24 March 2010

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

scientific article

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

scientific article published on 5 May 2015

Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive data.

scientific article published on 17 February 2009

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

scientific article published in 2022

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation

scientific article published on 31 December 2014

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

scientific article published on 14 January 2011

Linking data from hospital and cancer registry databases: should this be standard practice?

scientific article

Lymph node yield following colorectal cancer surgery.

scientific article published on 17 November 2010

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

scientific article

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer

scientific article published on 12 February 2013

Microsatellite instability status is critical to analysis of survival in stage II colon cancer

scientific article published on 09 January 2012

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

scientific article

Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer

scientific article

Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation

scientific article published in May 2011

Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.

scientific article published on November 2007

Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?

scientific article published on 05 August 2014

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

scientific article published on 02 July 2012

PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.

scientific article

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer

scientific article published on 30 April 2013

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

scientific article

Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes

scientific article published on 7 December 2009

Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.

scientific article published in January 2013

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

scientific article

Predictors of clinic non-attendance: opportunities to improve patient outcomes in colorectal cancer

scientific article published on 01 November 2010

Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data

scientific article

Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.

scientific article

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

scientific article published on 09 May 2019

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial

scientific article published on 7 August 2009

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

scientific article

Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer

scientific article published on 22 April 2011

Re: Residual treatment disparities after oncology referral for rectal cancer

scientific article published on 25 November 2008

Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13

scientific article published on 10 November 2011

Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".

scientific article published in January 2009

Risk-adjusted pathologic margin positivity rate: a problematic quality indicator

scientific article published on 23 March 2015

SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer

scientific article

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX s

scientific article

Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors

scientific article

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

scientific article published on 17 August 2020

Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.

scientific article published on 20 February 2008

Surgical oncology issues in locally advanced rectal cancer.

scientific article

Surveillance following treatment for colorectal cancer in Australia. Has best practice been adopted by medical oncologists?

scientific article published in June 2008

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations

scientific article published on 17 September 2013

Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001-2008

scientific article published on 01 October 2014

The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations

scientific article published on 24 January 2019

The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

scientific article

Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.

scientific article

Towards establishing a national colorectal cancer database: lessons learnt from Bio21 molecular medicine informatics model

scientific article published in September 2008

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

scientific article

Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice.

scientific article published on 17 August 2014

Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice

scientific article

Treatment with unfunded drugs in oncology: the impact of access programmes and clinical trials ⬇️

scientific article published on January 1, 2013

Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.

scientific article

Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?

scientific article published on 03 October 2007

List of works by Peter Gibbs

A critical review of the Glasgow Prognostic Score for colorectal cancer

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

APER rate has multiple limitations as an indicator of quality in rectal cancer surgery

Adjuvant chemotherapy use among older patients with stage III colon cancer

An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer.

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion

Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria

Assessing aneuploidy with repetitive element sequencing

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

Author reply: To PMID 22372920.

BioGrid Australia facilitates collaborative medical and bioinformatics research across hospitals and medical research institutes by linking data from diverse disease and data types

Blood-based protein biomarker panel for the detection of colorectal cancer

Cancer classification using the Immunoscore: a worldwide task force

Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.

Colorectal cancer screening: ensuring benefits outweigh the risks

Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology.

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

Comparing oncological outcomes of laparoscopic versus open surgery for colon cancer: Analysis of a large prospective clinical database.

Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

Comparison of ECOG/WHO Performance Status and ASA Score as a Measure of Functional Status

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

Cytosine methylation profiling of cancer cell lines.

DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Detection of circulating tumor DNA in early- and late-stage human malignancies

Developing a national database for metastatic colorectal cancer management: perspectives and challenges.

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.

Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives?

Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

Effect of Aspirin on Disability-free Survival in the Healthy Elderly

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.

Financial incentives in cancer care and impact on prescribing practice.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study

Guesstimates are not good enough for determining what is happening in routine care.

Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive data.

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

Linking data from hospital and cancer registry databases: should this be standard practice?

Lymph node yield following colorectal cancer surgery.

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer

Microsatellite instability status is critical to analysis of survival in stage II colon cancer

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer

Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation

Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.

Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes

Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

Predictors of clinic non-attendance: opportunities to improve patient outcomes in colorectal cancer

Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data

Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer

Re: Residual treatment disparities after oncology referral for rectal cancer

Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13

Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".

Risk-adjusted pathologic margin positivity rate: a problematic quality indicator

SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer